Zhejiang Tailin BioEngineering Co.,Ltd

Equities

300813

CNE100003S89

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-29 pm EDT			5-day change	1st Jan Change
19.63 ^CNY	-1.80%		-4.94%	-19.94%

May. 20	Zhejiang Tailin Bioengineering Co.,Ltd Announces Final Dividend Implementation Per A Shares for the Year 2023, Payable on 27 May 2024	CI
May. 15	Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2023	CI

Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2017

February 02, 2021 at 05:39 am EST

Zhejiang Tailin BioEngineering Co.,Ltd announced earnings results for the full year ended December 31, 2017. For the full year, the company announced sales was CNY 142.018 million. Operating income was CNY 46.879 million. Net income was CNY 44.987 million. Basic earnings per share from continuing operations was CNY 1.15.

Latest news about Zhejiang Tailin BioEngineering Co.,Ltd

Zhejiang Tailin Bioengineering Co.,Ltd Announces Final Dividend Implementation Per A Shares for the Year 2023, Payable on 27 May 2024	May. 20	CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2023	May. 15	CI
Zhejiang Tailin BioEngineering Co.,Ltd Announces Management Appointments	May. 15	CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for 2023	Apr. 23	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it expects to receive CNY 170 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	Dec. 11	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 11 May 2023	23-04-27	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Zhejiang Tailin Bioengineering Co.,Ltd. Proposes Final Cash Dividend for 2022	23-04-03	CI
Certain A Shares of Zhejiang Tailin BioEngineering Co.,Ltd are subject to a Lock-Up Agreement Ending on 15-JAN-2023.	23-01-14	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28	CI
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it has received CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	22-06-08	CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves the Final Cash Dividend for the Year 2021, Payable on May 18, 2022	22-05-10	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for the Year of 2021	22-04-19	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-18	CI
Zhejiang Tailin Life Science Co., Ltd. announced that it expects to receive CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	22-04-17	CI
Zhejiang Tailin Bioengineering Sells $33 Million RMB Convertible Bonds	21-12-28	MT
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2020, Payable on May 26 , 2021	21-05-18	CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Dividend for 2020	21-04-26	CI

Chart Zhejiang Tailin BioEngineering Co.,Ltd

Duration

Period

Chart Zhejiang Tailin BioEngineering Co.,Ltd

More charts

Company Profile

Zhejiang Tailin Bioengineering Co., Ltd. is a China-based company mainly engaged in pharmaceutical equipment business. The Company's main business is the research, development, manufacturing and sales of microbial detection and control technology system products, organic substance analysis instruments and other pharmaceutical equipment. Specific products include various consumables, instruments and equipment, which can be used alone or in combination for the production and quality of sterile drugs. The application areas that can be expanded include medical and health, food safety, disease prevention and control, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. The Company distributes its products within domestic market and to overseas markets.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ZHEJIANG TAILIN BIOENGINEERING CO.,LTD	-19.94%	296M
THERMO FISHER SCIENTIFIC	+6.02%	215B
DANAHER CORPORATION	+9.25%	187B
INTUITIVE SURGICAL, INC.	+19.58%	143B
BOSTON SCIENTIFIC CORPORATION	+29.74%	110B
SIEMENS HEALTHINEERS AG	+1.63%	64.68B
EDWARDS LIFESCIENCES CORPORATION	+15.27%	52.96B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2.69%	49.84B
AGILENT TECHNOLOGIES, INC.	-5.47%	38.32B
GE HEALTHCARE TECHNOLOGIES INC.	+1.58%	35.86B

Other Advanced Medical Equipment & Technology